Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - ...

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...

No drug is without potential side effects, and there are five major ones that people taking Ozempic, Wegovy or Mounjaro are ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...

By the end of the study, people on the maximum dose of Zepbound lost an average of about 50 ... lb (13.7 percent of their body weight) with Wegovy. More weight loss wasn’t the only advantage ...

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50 per cent more weight than those using rival Novo Nordisk's Wegovy.

Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.

The first head-to-head trial of two blockbuster weight-loss drugs has shown Mounjaro is more effective than rival Wegovy.

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...